Tandem Diabetes Care, Inc.

This study tested a smart insulin system called Control-IQ+ in 319 adults with type 2 diabetes who use insulin. The goal was to see if the technology helps control blood sugar levels better than standard care. Participants used either the smart system or their usual insulin routi…

This study tested a new insulin infusion set designed to be worn for up to 7 days in people with type 1 diabetes. 260 participants used the set for 12 consecutive wear periods at home. The goal was to see if the set could safely deliver insulin for a full week without needing rep…